Geospiza’s GeneSifter software chosen for managing Eurofins MWG Operon's DNA sequencing systems

NewsGuard 100/100 Score

Eurofins MWG Operon and Geospiza, today announced that Eurofins MWG Operon has selected Geospiza’s GeneSifter® Lab Edition software to manage its DNA sequencing systems and further enhance its market leading customer experience.

“At Operon, we are constantly identifying new and cost effective ways to enhance our services and ensure that our customers have access to the most advanced solutions on the market,” said Martin Kunz, Chief Technology Officer at Eurofins MWG Operon. “It was clear to us that Geospiza’s GeneSifter software was the best in class product to further automate our systems while delivering us the best return on our investment capital. Geospiza’s 10 years of experience in lab automation and impressive list of customers gave us the confidence that we could implement the solution rapidly – so that our customers will quickly see the benefits of this investment.”

Eurofins MWG Operon has been providing sequencing services for over a decade, and has recently renewed its commitment to expand and improve those services. “We are excited to work with Eurofins MWG Operon to help them reach their goals for growing their business,” said Todd Smith, CSO of Geospiza. “Geospiza is committed to delivering our customers innovative products and services to help them achieve exceptional business results.”

The web-based architecture and delivery capabilities of Geospiza’s GeneSifter are particularly well suited to support multi-site and multi-national organizations like Eurofins MWG Operon. Helaman Escobar, Director of DNA Sequencing at Eurofins MWG Operon states, “In addition to the many customer benefits of GeneSifter, we will also realize more efficient operations through the implementation. Those efficiencies will enable us to continue to offer excellent quality and service cost-effectively.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LMU researchers shed light on DNA repair mechanisms in Cockayne syndrome